The diagnostic assessment of patients with Interstitial Lung Disease (ILD) can be
challenging due to the large number of possible causes. Moreover, the diagnostic approach …

Interstitial lung disease (ILD) may occur in patients with a rheumatic autoimmune disease
(AD), increasing their risk of morbidity and mortality. However, little is known about the …

Objective. Interstitial lung diseases (ILD) form a diverse group of parenchymal lung
disorders. Currently, a multidisciplinary team (MDT) including pulmonologists, radiologists …

Background: Interstitial lung diseases (ILDs) are often associated with rheumatic diseases.
Their early diagnosis and management are not only difficult, but also crucial, because they …

Interstitial lung diseases (ILD), also defined as diffuse parenchymal lung diseases (DPLD)
include a heterogeneous group of pulmonary disorders. They may be caused by an …

Multidisciplinary team (MDT) discussion is the gold standard in the management of
interstitial lung disease (ILD). The rheumatologist is not routinely involved in MDT, even if up …

Background The benefit of routinely measuring autoimmune biomarkers to evaluate patients
with interstitial lung disease (ILD) remains debated outside specific contexts such as …

To date, there is no clear agreement regarding which is the best method to detect a
connective tissue disease (CTD) during the initial diagnosis of interstitial lung diseases …

Interstitial lung disease (ILD) encompasses a wide range of parenchymal lung pathologies
with different clinical, histological, radiological, and serological features. Follow-up …

Background: Interstitial lung diseases (ILDs) are a group of heterogeneous diseases
characterized by inflammation and/or fibrosis of the lung interstitium, leading to a wide range …